A Study Evaluating the Long-Term Safety of ICA-17043 in Sickle Cell Disease Patients With or Without Hydroxyurea Therapy

SUNY Downstate Medical Center, Brooklyn

New York Methodist Hospital, Brooklyn

Thomas Jefferson University Hospital, Philadelphia

Johns Hopkins University School of Medicine, Baltimore

Virginia Commonwealth University, Richmond

Wake Forest University School of Medicine, Winston-Salem

University of North Carolina Hospitals, Chapel Hill

Duke University Medical Center, Durham

East Carolina University School of Medicine, Greenville

Medical University of South Carolina, Charleston

Medical College of Georgia, Augusta

Memorial Health University Medical Center, Savannah

Century Clinical Research, Inc., Holly Hill

University of Florida Health Science Center, Jacksonville

University of South Alabama, Mobile

University of Mississippi Medical Center, Jackson

University of Cincinnati, Cincinnati

Wayne State School of Medicine, Detroit

University of Illinois Medical Center, Chicago

Sickle Cell Center of Northern Louisiana, Shreveport

Arkansas Children's Hospital, Little Rock

Baylor College of Medicine, Houston

University of Colorado Health Sciences Center, Denver

Children's Hospital Oakland, Oakland

University of California Davis Medical Center, Sacramento

Brigham and Women's Hospital, Boston

Hackensack University Medical Center, Hackensack

Robert Wood Johnson Medical Center, New Brunswick

Newark Beth Israel Medical Center, Newark

St. Christopher's Hospital for Children, Philadelphia

Medical College of Virginia, Richmond